Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
46,691,176
-
Total 13F shares
-
16,612,608
-
Share change
-
+1,228,094
-
Total reported value
-
$400,026,000
-
Price per share
-
$24.08
-
Number of holders
-
54
-
Value change
-
+$731,531
-
Number of buys
-
40
-
Number of sells
-
29
Institutional Holders of 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) as of Q2 2021
As of 30 Jun 2021,
4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,612,608 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, BVF INC/IL, JANUS HENDERSON GROUP PLC, Casdin Capital, LLC, FMR LLC, ArrowMark Colorado Holdings LLC, Aquilo Capital Management, LLC, Octagon Capital Advisors LP, BlackRock Inc., and ALKEON CAPITAL MANAGEMENT LLC.
This page lists
54
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.